AgingResearch.NewsJoin free

Merkel cell polyomavirus seropositivity

There is 1 paper on Merkel cell polyomavirus seropositivity in aging research: 1 observational study in people. The newest story, Nov 11, 2026: “Genetic study links Epstein-Barr antibodies to prostate cancer”.

Biomarker

1 paper studies it1 finding

1 new paper in 30 daysSee all 1 papers on Merkel cell polyomavirus seropositivity

“Merkel cell polyomavirus seropositivity with reduced risk (meta OR = 0.967, P = 1.6 × 10-5)”
Viral infections and the risk of prostate cancer: a two-sample Mendelian randomization study with multi-cohort replication and an extended viral antibody panelInfectious agents and cancer2026doi:10.1186/s13027-026-00823-x
  • Humans1

Associations

1

Prostate cancer

downin humans1OR 0.967

1 study

  1. Merkel cell polyomavirus seropositivity is associated with prostate cancer in humans (Genetically proxied seropositivity; extended 37-trait panel) (Meta OR 0.967; P = 1.6 × 10-5).

    “Merkel cell polyomavirus seropositivity with reduced risk (meta OR = 0.967, P = 1.6 × 10-5)”

    HumansGenetically proxied seropositivity; extended 37-trait panel

    Genetic study links Epstein-Barr antibodies to prostate cancer

    Infectious agents and cancer

More on Prostate cancer

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Infectious Agents and Cancer

Genetic study links Epstein-Barr antibodies to prostate cancer

Across three datasets, genetically predicted antibody levels were linked to higher prostate cancer odds, with a pooled odds ratio of 1.074, versus 1 for no association.Across three datasets, genetically predicted antibody levels were linked to higher prostate cancer odds, with a pooled odds ratio of 1.074, versus 1 for no association.

Mendelian randomizationProstate cancer
Paper

Related